Physician profile
Dylan Jay Mathews
NPI 1376047472
$8,648.66
in general payments reported to CMS, 2019-2025
11 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $6,462 · 2023: $1,838 · 2024: $56.80 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Travel and Lodging: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.66 |
| Travel and Lodging | $577.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $6,090.35 | 2022-2023 | |
| Stryker Corporation | $745.34 | 2022-2024 | Radius, Hoffmann, Blueprint Patient Specific Instrumentation |
| Medacta USA, INC. | $565.15 | 2023 | Amistem, Gmk Sphere |
| Integra Lifesciences Corporation | $355.81 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $228.84 | 2022 | |
| Depuy Synthes Sales INC. | $203.76 | 2023-2025 | Tfn-Advance |
| Anika Therapeutics, INC. | $189.28 | 2023 | Ovomotion, Drawtight, X-Twist |
| Acumed LLC | $140.25 | 2023 | Acumed |
| Pacira Pharmaceuticals Incorporated | $72.92 | 2023 | Exparel |
| Solventum Corporation | $36.70 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Spoton |
| Kci USA, INC. | $20.26 | 2023 | Ranger, V.A.C. Dermatac, Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.